Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar)

Despite decades of effort, pancreatic adenocarcinoma (PDAC) remains an intractable clinical challenge. An insufficient understanding of mechanisms underlying tumor cell responses to chemotherapy contributes significantly to the lack of effective treatment regimens. Here, paclitaxel, a first-line che...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Cell Proteomics
Hlavní autoři: Wang, Xue, Niu, Jin, Li, Jun, Shen, Xiaomeng, Shen, Shichen, Straubinger, Robert M., Qu, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society for Biochemistry and Molecular Biology 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5880105/
https://ncbi.nlm.nih.gov/pubmed/29358341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.RA117.000519
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky